Form 4: Guardant Health Director Krognes Reports RSU Vesting

Guardant Health Director Steve E. Krognes reported the vesting and acquisition of 154 shares of common stock from restricted stock units.

Summary

• Steve E. Krognes, a Director at Guardant Health, Inc. (GH), reported a transaction involving the vesting of Restricted Stock Units (RSUs).
• On December 31, 2025, Krognes acquired 154 shares of Guardant Health Common Stock through the exercise or conversion of derivative securities at a price of $0.
• Following this transaction, Krognes beneficially owns 18,745 shares of Common Stock.
• The transaction is related to a restricted stock unit award granted on August 9, 2022.
• 25% of the original RSU award vested on June 30, 2023, with the remaining 75% vesting in substantially equal monthly installments over a three-year period from June 30, 2023.
• Krognes beneficially owns 926 Restricted Stock Units following this reported transaction.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine insider transaction (vesting of RSUs) which indicates a director's continued equity ownership and alignment with shareholder interests, without implying any new strategic or operational developments.

Positives

• The transaction reflects a director's continued equity stake in Guardant Health, aligning their interests with shareholders.
• The vesting of Restricted Stock Units is a routine compensation event, indicating ongoing commitment and employment of a key director.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the scheduled vesting of existing Restricted Stock Units.

Industry Context

This is a routine insider transaction disclosure (Form 4) and does not provide broader industry context or competitive analysis.

Stakeholder Impact

• Shareholders: The transaction demonstrates a director's ongoing equity stake in the company, which can be viewed positively as it aligns management's interests with those of shareholders.

Next Steps

• The remaining 75% of the RSU award granted on August 9, 2022, will continue to vest in substantially equal installments on each monthly anniversary of June 30, 2023, over the three-year period thereafter.

Key Dates

Keywords

Guardant Health, GH, Form 4, Insider Transaction, Steve Krognes, Restricted Stock Units, RSU Vesting, Common Stock